Ballicules.com

Norgestimate

in ORTHO TRI-CYCLEN

What it isProgestin with low androgenic activity, used in combined oral contraceptives.

Why this oneIts low androgenicity is why it is chosen for acne, and it carries an acne indication.

What limits itCombined use brings VTE risk, higher with smoking and over 35. Efficacy depends on daily adherence.

FDA-approved for

FDA label

BOXED WARNING COCs contraindicated in women >35 who smoke; smoking raises risk of serious cardiovascular events.
FDA dosingPopulationStartTargetMax
ContraceptionFemales of reproductive potential1 active tablet QD1 tablet QD (21 active + 7 inactive per 28-day cycle)

Renal Undefined

Hepatic Contraindicated in liver disease or hepatic tumors

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Contraindicated in pregnancy; no increased birth-defect risk with inadvertent early exposure.

Lactation Not recommended; can decrease milk production. Small amounts of steroids present in milk.

⚠ BOXED WARNING

Cost, est. cash$10–$300/month

Generic entry2002

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryX

Defining liabilityVenous thromboembolism and hormone-related adverse effects; estrogen also lowers lamotrigine exposure.

Active metabolites

Mechanism of action: Norgestimate ballicule

Norgestimate ballicule: receptor binding, kinetics and half-life diagram

Open Norgestimate in the interactive console ↗

Memory aids: mascots and interaction avatars

Norgestimate ORTHO TRI-CYCLEN mascot mnemonic cartoon
“North estimator”
Norgestimate CYP3A4 substrate avatar
CYP3A4 substrate

Open Norgestimate in the interactive console ↗